Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

10.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
10.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reader response: Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update.

Neurology·2020
Same author

Sleep Dysfunction in Parkinson's Disease.

Journal of clinical and diagnostic research : JCDR·2016
Same author

Clinical features of the geste antagoniste in cervical dystonia.

Advances in neurology·2003
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System
12:06

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Published on: May 12, 2011

21.5K

Traumatic Optic Neuropathy - A Conundrum.

Vinoth Kanna Selvaraj1, Ramachandran Viswanathan1, Vasudevan Devanathan2

  • 1Assistant Professor, Department of Neurology, Saveetha Medical College Hospital, Saveetha University , Thandalam, Kancheepuram, Tamil Nadu, India .

Journal of Clinical and Diagnostic Research : JCDR
|May 3, 2016
PubMed
Summary

Delayed visual loss after head trauma can be reversed with steroid therapy, even when initial evaluations and blood transfusions fail. This case highlights steroids

Keywords:
Delayed visual lossErythropoietinIron deficiency anaemiaSteroid

More Related Videos

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival
09:07

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

32.0K
Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 21, 2026

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System
12:06

Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System

Published on: May 12, 2011

21.5K
An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival
09:07

An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell Survival

Published on: April 25, 2011

32.0K
Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

1.6K

Area of Science:

  • Neuro-ophthalmology
  • Traumatic Brain Injury Research

Background:

  • Visual impairment following head injury presents diagnostic challenges, particularly with delayed symptom onset.
  • Initial normal ophthalmological examinations can be misleading without repeated, formal clinical evaluations and electrophysiology.

Observation:

  • A 32-year-old female experienced delayed visual loss after head trauma, accompanied by anemia.
  • She did not improve with blood transfusion but showed immediate improvement after steroid therapy administered seven days post-trauma.

Findings:

  • This case suggests a potential role for steroid therapy in delayed, progressive visual loss following head trauma.
  • It indicates a need to re-evaluate steroid efficacy in specific presentations of post-traumatic visual disturbance, distinct from acute onset symptoms.

Implications:

  • The findings prompt a re-analysis of steroid therapy for specific types of delayed post-traumatic visual loss.
  • Understanding different pathologies in acute versus delayed presentations is crucial for effective treatment strategies.